Literature DB >> 36105029

Acupuncture relieves the visceral pain of diarrhea-predominant irritable bowel syndrome rats by regulating P2X4 expression.

He-Yong Tang1, Xi-Qiuyu Chen1, Hao Wang1, Hao-Ran Chu2, Cai-Feng Zhu2, Shun Huang1, Meng-Ting Zhang1, Guo-Ming Shen1.   

Abstract

OBJECTIVES: We researched the effect and mechanism of acupuncture treatment for visceral pain in rats with diarrhea-predominant irritable bowel syndrome (IBS-D).
METHODS: We set up a rat model of IBS-D with chemical and chronic- and acute-pressure stimulations. Then, the IBS-D rats were treated with acupuncture or 5-BDBD, and the therapeutic efficacy of acupuncture in IBS-D rats was assessed by means of the Bristol scale, diarrhea index, abdominal withdrawal reflex (AWR) score, mast cell count and histologic staining.
RESULTS: Acupuncture significantly decreased clinical symptoms in IBS-D rats after a 14 day-treatment. Furthermore, significant down-regulation of P2X4, OX42, BDNF (brain-derived neurotrophic factor) and IRF-5 (interferon regulatory factor 5) expressions were observed in the IBS-D rats, along with the decreased inflammatory factors [interleukin 1 beta (IL-1β), tumor necrosis factor alpha (TNF-α), and interleukin 6 (IL-6)], chemokines [monocyte chemoattractant protein-1 (MCP-1), regulated on activation, normal T cell expressed and secreted (RANTES), and C-X-C motif chemokine ligand 1 (CXCL1)], and neurotransmitters [substance P (SP), 5-hydroxytryptamine (5-HT), and calcitonin gene-related peptide (CGRP)]. 5-BDBD treatment had a similar effect on IBS-D rats.
CONCLUSIONS: Acupuncture can effectively alleviate abdominal pain by decreasing visceral hypersensitivity and controlling the expression of P2X4 and spinal microglial inflammation in IBS rats. AJTR
Copyright © 2022.

Entities:  

Keywords:  IBS-D rat; P2X4; acupuncture; visceral pain

Year:  2022        PMID: 36105029      PMCID: PMC9452363     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   3.940


  52 in total

1.  Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain.

Authors:  S M Sweitzer; P Schubert; J A DeLeo
Journal:  J Pharmacol Exp Ther       Date:  2001-06       Impact factor: 4.030

2.  IRF-5 Promotes Cell Death in CD4 T Cells during Chronic Infection.

Authors:  Aymeric Fabié; Linh Thuy Mai; Xavier Dagenais-Lussier; Akil Hammami; Julien van Grevenynghe; Simona Stäger
Journal:  Cell Rep       Date:  2018-07-31       Impact factor: 9.423

3.  [Acupuncture Treatment Reduces Body Weight Possibly by Down-regulating Insulin and Leptin Resistance, and Up-regulating Soluble Leptin Receptor Level in Prediabetic Patients].

Authors:  Zhi-Ming Zhao; Chun-Li Liu; Qun-Yan Zhang; Bei-Bei Zhang; Jun-Hao Guo; Ai-Hong Yuan; Hui Cai
Journal:  Zhen Ci Yan Jiu       Date:  2018-08-25

4.  IRF5 guides monocytes toward an inflammatory CD11c+ macrophage phenotype and promotes intestinal inflammation.

Authors:  Alastair L Corbin; Maria Gomez-Vazquez; Dorothée L Berthold; Moustafa Attar; Isabelle C Arnold; Fiona M Powrie; Stephen N Sansom; Irina A Udalova
Journal:  Sci Immunol       Date:  2020-05-22

Review 5.  Role of the P2X4 receptor in neuropathic pain.

Authors:  Kazuhide Inoue
Journal:  Curr Opin Pharmacol       Date:  2019-03-14       Impact factor: 5.547

6.  Fos-like proteins in the lumbosacral spinal cord following noxious and non-noxious colorectal distention in the rat.

Authors:  Richard J Traub; Patty Pechman; Michael J Iadarola; G F Gebhart
Journal:  Pain       Date:  1992-06       Impact factor: 6.961

Review 7.  [Neuropathic pain and ATP receptors in spinal microglia].

Authors:  Makoto Tsuda; Kazuhide Inoue
Journal:  Brain Nerve       Date:  2007-09

8.  [Bristol Stool Chart: Prospective and monocentric study of "stools introspection" in healthy subjects].

Authors:  G Amarenco
Journal:  Prog Urol       Date:  2014-08-22       Impact factor: 0.915

9.  New Pathways, New Targets: Visceral Hypersensitivity Pathogenesis in Irritable Bowel Syndrome.

Authors:  Kenneth Barshop; Kyle Staller
Journal:  Clin Transl Gastroenterol       Date:  2016-02-25       Impact factor: 4.488

Review 10.  New insights into irritable bowel syndrome: from pathophysiology to treatment.

Authors:  Alexandros Hadjivasilis; Constantinos Tsioutis; Adamantios Michalinos; Dimitrios Ntourakis; Dimitrios K Christodoulou; Aris P Agouridis
Journal:  Ann Gastroenterol       Date:  2019-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.